Jerome Sarris


CONNECT | LINKEDIN (opens in a new window)

PHD
Deputy director, NICM
Executive committee member, NICM
Professor of integrative mental health, NICM
Health minds research program lead, NICM


Professor Jerome Sarris

Jerome Sarris is Professor of integrative mental health and deputy director at NICM. He moved from clinical practice as a Naturopath, Nutritionist, and Acupuncturist to academic work, and completed a doctorate at The University of Queensland in the field of psychiatry. Professor Sarris undertook his postdoctoral training at The University of Melbourne, Department of Psychiatry; The Centre for Human Psychopharmacology, Swinburne University of Technology; and The Depression Clinical and Research Program at Harvard Medical School (MGH). He has a particular interest in anxiety and mood disorder research pertaining to nutraceutical psychopharmacology, in complementary and integrative medicine, lifestyle medicine, and psychotropic plant medicine research.

Professor Sarris has 117 publications (1st/2nd/Senior author on 91 per cent of publications) with an H-Index of 29 (cited over 2,800 times), and has published in many eminent psychiatry journals including The American Journal of Psychiatry, Lancet Psychiatry, and World Psychiatry (in addition to a reviewer for 70 journals).


Research focus

  • Evidence-based use of nutraceuticals and lifestyle modifications in the treatment of psychiatric disorders, specifically mood and anxiety disorders
  • Adjunctive Pharmacotherapies
  • Integrative Models
  • Lifestyle Medicine
  • Nutraceutical Psychopharmacology
  • Pharmacogenomics
  • Clinical trials and evidence based practice

Awards and recognitions

  • Honorary Principal Research Fellow, The University of Melbourne, Department of Psychiatry
  • ARCADIA Nutraceutical and Lifestyle Medicine Research Group Head (Honorary position)
  • The International Network of Integrative Mental Health (INIMH) Board Member (a founding Vice-Chair)
  • International Society for Nutritional Psychiatry Research (ISNPR) Executive Committee member
  • American Botanical Council Board Member
  • Research Committee Deputy Chair and Research Subcommittee Chair(Department of Psychiatry; University of Melbourne)
  • Group of Eight Future Research Leaders Program
  • NHMRC grants, Beyond Blue, Swiss National Science Foundation, grant reviewer
  • TGA contributor to GP clinical guidelines on depression treatment (evidence-based CAMs)
  • Ethics committee member Endeavour College of Natural Health
  • Assisted TGA Kava policy direction
  • University of Melbourne, Department of Psychiatry "Cato Chair Champion"
  • Section Editor (Mental Health) for Advances in Integrative Medicine (Elsevier)
  • NHMRC Research Translation Faculty Member 2012-
  • NHAA Distinguished Contribution to Research Award 2014
  • ANS Dr Tini Gruner Naturopathic Educator of the Year Award 2016

Projects and grants

Professor Sarris has been collaboratively awarded over $6.95 million dollars in personal and study grants, including being CIA on three multicentre NHMRC Project Grants.

See a full list of past and current projects (opens in a new window).


Education

  • PhD, The University of Queensland

Publications

Journal Articles

2016

Sarris J* (2016). Clinical Use of Nutraceuticals in the Adjunctive Treatment of Depression in Mood Disorders. Australasian Psychiatry (accepted).

Firth J, Stubbs B, Sarris J*, Rosenbaum S, Teasdale S, Berk M, Yung AR (2016) The effects of vitamin and mineral supplements on symptoms of schizophrenia: a systematic review and meta-analysis. Psychological Medicine (accepted).

Heerman C, Absenger W, Sarris J* (2016). Videoconference mind-body group therapy in a public mental health setting: A pilot study. Journal of Technology in Behavioral Science (accepted).

Smith D, Sarris J*, Dowling N, O'Connor M, Ng C (2016). Adjunctive low-dose docosahexaenoic acid (DHA) for Major Depression (DHA) for Major Depression: An Open-Label Pilot. Nutritional Neuroscience (accepted).

Pompili M, Serafini G, Lamis D, Sarris J* (2016). Polyunsaturated fatty acids and suicide risk in Mood Disorders: A systematic review. Progress in Neuropsychopharmacology & Biological Psychiatry (accepted).

Rossell SL, Francis PS, Galletly C, Harris A, Siskind D, Berk M, Bozaoglu K, Dark F, Dean O, Liu D, Meyer D, Neill E, Phillipou A, Sarris J*, Castle DJ (2016). N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry 16(1):320

Sarris J*, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng C (2016). Adjunctive Nutraceuticals in the Treatment of Depression: A Systematic Review and Meta-analyses. American Journal of Psychiatry (in press).

Sarris J*, Oliver G, Camfield DA, Dean O (2016). Participant Characteristics as Modifiers of Response to N-Acetyl Cysteine (NAC) in Obsessive-Compulsive Disorder. Clinical Psychological Science (accepted).

McIntyre E, Saliba A, Wiener K, Sarris J* (2016) Herbal medicine use behaviour in Australian adults who experience anxiety: a descriptive study. BMC Complementary and Alternative Medicine (accepted).

2015

Sarris J*, Logan A, Akbaraly T,, Amminger GP, Balanzá-Martínez V, Freeman MP,  Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN (2015). Nutritional Medicine as Mainstream in Psychiatry. The Lancet Psychiatry, 2(3), pp.271-274.

Sarris J*, Oliver G, Camfield D, Dean OM, Dowling N, Smith D, Murphy J, Menon R, Berk M, Blair-West S, Ng C (2015) N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-week Double-blind, Randomised, Placebo-Controlled Study. CNS Drugs, 29(9), pp.801-900. 

Kean J, Kaufman J, Lomas J, Goh A, White D, Simpson D, Scholey A, Singh H, Zangara A, Sarris J*, Stough C (2015). A randomized controlled trial investigating the effects of a special extract of Bacopa monnieri (CDRI 08) on hyperactivity and inattention in male children and adolescents: BACHI Study Protocol (ANZCTRN12612000827831). Nutrients, 7(12), pp.9931-9945. [Contributed to the study design and manuscript draft: 20%].

Savage K, Stough C, Byrne G, Scholey A, Bousman C, Murphy J, McDonald P, Suo C, Hughes M, Teschke R, Thomas S, Xing C, Sarris J* (2015). Kava for the Treatment of Generalised Anxiety Disorder (K-GAD): Study protocol for a randomized, controlled trial. Trials, 16(493).

Sarris J*, Nishi D, Xiang YT, Su KP, Bannatyne A, Oliver G, Kua EK, Ng CH (2015). Implementation of Psychiatric-Focused Lifestyle Medicine Programs in Asia. Asia Pacific Psychiatry, 7(4), pp.345-54.

Wong P, Camfield D, Woods W, Sarris J, Pipingas A (2015). Spectral power and functional connectivity changes during mindfulness meditation with eyes open: A magnetoencephalography (MEG) study in long-term meditators. International Journal of Psychophysiology, 98(1), pp.95-111. [Contributed to manuscript design & draft: 25%].

Sarris J*, Logan A, Akbaraly T,, Amminger GP,  Balanzá-Martínez V, Freeman MP,  Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN (2015). International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry. World Psychiatry, 14(3), pp.370-371.

Sarris J*, Price LH, Carpenter L, Tyrka AR, Ng CH, Papakostas GI, Jaeger A, Fava M, Mischoulon D (2015). Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial. Pharmacopsychiatry, 48(4-5).

McIntyre E, Saliba A, Wiener K, Sarris J* (2015). Herbal medicine use in adults with anxiety: A narrative literature review. Advances in Integrative Medicine (in press).

Sarris J*, Stough C, Bousman C, Murphy J, Savage K, Smith DJ, Menon R, Chamoli S, Oliver G, Berk M, Byrne GJ, Ng C, Mischoulon D (2015) An Adjunctive Antidepressant Nutraceutical Combination in Treating Major Depression: Study Protocol, and Clinical Considerations. Advances in Integrative Medicine, 2(1), pp.49-55.

2014

Oliver G, Dean OM, Camfield DA, Blair-West S, Ng C, Berk M, Sarris J* (2014) N-Acetyl Cysteine (NAC) in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review. Clinical Psychopharmacology and Neuroscience, 13(1), pp.12-24.

Sarris J*, Papakostas G, Vitolo O, Fava M, Mischoulon D (2014) S-Adenosyl Methionine   (SAMe) versus Escitalopram and Placebo in Major Depression RCT: Efficacy and Effects of Histamine and Carnitine as Moderators of Response. Journal of Affective Disorders, 164, pp.76-81.

Dean OM, Turner A, Malhi GS, Ng C, Cotton SM, Dodd S, Sarris J, Samuni Y, Tanious M, Dowling N, Waterdrinker A (2014) Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression. Revista Brasileira de Psiquiatria, 37(1), pp. 3-12. [Contributed to the study design and draft: 20%].

Bousman CA, Sarris J*, Won ES, Chang HS, Singh A, Lee HY, Ham BJ, Tan CH, Lee MS, Ng C  (2014) Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism. Journal of clinical psychopharmacology, 34(5), pp.645-648.

Sarris J*, O'Neil A, Coulson C, Schweitzer I, Berk M (2014) Lifestyle Medicine for Depression. BMC Psychiatry, 14(1), pp.1-28.

Sarris J*, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I (2013) Kava in the Treatment of Generalized Anxiety Disorder:  A Double-Blind, Randomized, Placebo-Controlled Study. Journal of Clinical Psychopharmacology, 33(5), pp.643-648.

Pipingas A, Camfield DA, Stough C, Scholey AB, Cox KH, White D, Sarris J, Sali A, Macpherson H (2014) Effects of multivitamin, mineral and herbal supplement on cognition in younger adults and the contribution of B group vitamins. Hum Psychopharmacol, 1, pp.73-82. [Contributed to study design & implementation: 25%].

Sarris J*, Gadsden S, Schweitzer I (2014) Naturopathic Medicine for Treating Self-Reported Depression and Anxiety: An Observational Pilot Study of Naturalistic Practice. European Journal of Integrative Medicine, 1(2), pp.87-92.

2013

Sarris J*, Nierenberg AA, Schweitzer I, Alpert JE, Rosenbaum JF, Iovieno N, Covino J, Fava M, Mischoulon D (2013) Conditional Probability of Response or Non-Response of Placebo Compared to Antidepressants or St John's wort in Major Depressive Disorder. Journal of Clinical Psychopharmacology, 33(6), pp.827-830.

Ng C, Sarris J*, Singh A, Bousman CA, Byron K, Smith D, Schweitzer I (2013) Pharmacogenetic Polymorphisms and Response to Escitalopram and Venlafaxine over 8 Weeks in Major Depression. Human Psychopharmacology, 28(5), pp.516-522.

Wardle J, Sarris J* (2014). Student attitudes towards clinical teaching resources in complementary medicine: a focus group examination of Australian naturopathic medicine students. Health Information and Libraries Journal, 31(2), pp. 123-132.

Camfield DA, Wetherell M, Scholey A, Cox K, Fogg E, White D, Sarris J, Kras M, Stough C, Sali A, Pipingas A (2013) The effects of Multivitamin Supplementation on Diurnal Cortisol Secretion and Perceived Stress. Nutrients, 5(11), pp.4429-4450. [Contributed to the study design and implementation, and draft: 20%].

Sarris J* (2013). Nutrients and Herbal Medicine Supplements for Mental Health. Australian Prescriber, 37, pp.90-93.

Camfield DA, Scholey A, Cox K, White D, Sarris, J Stough C, Pipingas A, (2013) The effects of Multivitamin Supplementation on Mood and General Well-being in healthy young adults: a laboratory and at-home mobile phone assessment. Appetite, 69, pp.123-136. [Contributed to the study design and implementation: 20%].

Sarris J*, Glick R, Hoenders RJ, Duffy J, Lake J (2013) Integrative Mental Healthcare White Paper: Establishing a New Paradigm through Research, Education, and Clinical Guidelines. Advances in Integrative Medicine, 1(1), pp.9-16.

Sarris J*, Glick R, Helgason C, Veiser C, Lake J (2013) The International Network of Integrative Mental Health. Advances in Integrative Medicine (invited editorial); 1;1.

Kean J, Camfield DA, Sarris J, Kras M, Scholey A, Stough C (2013) A randomized controlled trial investigating the effects of PCSO-524(R), a patented oil extract of the New Zealand Green Lipped Mussel (Perna Canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: Study protocol ACTRN12610000978066. Nutrition Journal, 12(100)[Contributed to study design and draft: 20%].

Schweitzer I, Sarris J*, Tuckwell V, Maguire K, Ng C (2013) Aripiprazole as Augmentation Therapy in Bipolar Patients with Current Minor or Subsyndromal Mood Symptoms. International Journal of Bipolar Disorder, 1, pp.4.

Sarris J* (2013) St John's wort in the Treatment of Psychiatric Disorders. Psychiatric Clinics of North America (invited review), 36(1), pp.65-72.

Sarris J*, Stough C, Teschke R, Wahid ZT,  Bousman CA, Murray G, Savage KM, Mouatt P, Ng C, Schweitzer  I (2013) Kava for the Treatment of Generalized Anxiety Disorder (KALM Study): Analysis of Adverse Reactions, Liver Function, Addiction, and Sexual Effects. Phytotherapy Research, 27(11), pp.1723-1728.

Helgason C, Sarris J* (2013) Mind-Body Medicine for Schizophrenia and Psychotic Disorders: A Review of the Evidence. Clinical Schizophrenia & Related Psychoses, 7(3), pp.138-148.

Sarris J*, McIntyre E, Camfield D (2013). Plant-Based Medicines for Anxiety Disorders Part 2: A Systematic Review of Clinical Studies. CNS Drugs (invited review), 27(4), pp.301-319.

Sarris J*, McIntyre E, Camfield D (2013). Plant-Based Medicines for Anxiety Disorders Part 1: A Review of Preclinical Studies. CNS Drugs (invited review), 27(3), pp.207-219.

Sarris J*, LaPorte E, Scholey A, King R, Pipingas A, Schweitzer I, Stough C (2013) Does a Medicinal Dose of Kava Impair Driving? A Randomized, Placebo-controlled, Double-Blind Study. Traffic Injury Prevention, 14(1), pp.13-17.

2012

Sarris J*, Camfield DA, Scholey A, Stough C, Fogg E, Kras M, White D, Sali A, Pipingas A (2012) Participant Experiences from Chronic Administration of a Multivitamin Versus Placebo on Subjective Health and Wellbeing: A Double-Blind Qualitative Analysis. Nutrition Journal, 11(1), pp. 110-119.

Sarris J*, Schweitzer I, Mischoulon D (2012) Are St John's wort and SSRI Antidepressants Really Ineffective in Treating Depression? Australian Journal of Herbal Medicine, 24(4), pp.4-5.

Sarris J* (2012) Chinese Herbal Medicine for Treating Sleep Disorders: Poor Methodology Restricts Any Clear Conclusion. Sleep Medicine Reviews (invited editorial), 16(6), pp.493-495.

Sarris J*, Moyland S, Camfield D, Pase M, Mischoulon D, Berk M, Jacka F, Schweitzer I (2012) Complementary Medicine, Exercise, Meditation, Diet, and Lifestyle Modification for Anxiety Disorders: A Review of Current Evidence. Evidence Based Complementary Medicine. 

Teschke R, Sarris J*, Lebot V (2012) Contaminant Hepatotoxins as Culprits for Kava Hepatotoxicity - Fact or Fiction? Phytother Res, 27(3), pp.472-474.

Sarris J*, Scholey A, Schweitzer I, Bousman C, LaPorte E, Ng C, Murray G, Stough C (2012) The Acute Effects of Kava and Oxazepam on Anxiety, Mood, Neurocognition, and Genetic Correlates: A Randomized, Placebo-controlled, Double-Blind Study. Human Psychopharmacology: Clinical and Experimental, 27(3), pp.262-269.

Sarris J*, Fava, M, Schweitzer I, Mischoulon, D (2012) St John's wort (Hypericum perforatum) versus Sertraline and Placebo in Major Depressive Disorder: Continuation Data from a 26 week RCT. Pharmacopsychiatry, 45(7), pp.275-278.

Berk M, Sarris J*, Cousan CE, Jacka FN (2012) Lifestyle Management of Unipolar Depression. Acta Psychiatr Scand, Supp 443(127), pp.38-54 .

Sarris J* (2012) Current Challenges in Appraising Complementary Medicine Evidence. Medical Journal of Australia (MJA), 196(5), pp.310-311.

Pase M, Kean J, Sarris J, Neale C, Scholey A, Stough C (2011) The cognitive enhancing effects of Bacopa monneri: A systematic review of randomized, controlled human clinical trials. Journal of Alternative and Complementary Medicine (JACM), 18(7), pp.647-652
[Contributed to manuscript design, analysis of data, and draft: 20%].

Sarris J*, Mischoulon D, Schweitzer I (2012) Omega-3 for Bipolar Disorder: Meta-analyses of use in mania and bipolar depression. Journal of Clinical Psychiatry, 73(1), pp.81-86.

2011

Sarris J*, Mischoulon D, Schweitzer I (2011) Adjunctive Nutraceuticals with Standard    Pharmacotherapies in Bipolar Disorder: A Systematic Review of Clinical Trials. Bipolar Disorders, 13(5-6), pp.454-65.

Sarris J* (2011) Whole System Research of Naturopathy and Medical Herbalism for Improving Mood and Reducing Anxiety. Australian Journal of Medical Herbalism, 25(1).

Teschke R, Sarris J*, Schweitzer I (2011) Kava hepatotoxicity in traditional and modern use: The presumed Pacific kava paradox hypothesis revisited. British Journal of Clinical Pharmacology, 73(2), pp.170-174.

Sarris J*, Kean J, Schweitzer I, Lake J (2011) Complementary Medicine Natural Products (Herbal and Nutritional Medicines) for the Treatment of ADHD: A Systematic Review. Complementary Therapies in Medicine, 19(4), pp.216-227.

Sarris J*, Camfield D, Berk M (2011) Complementary Medicine, Self-Help, and Lifestyle Interventions for Obsessive Compulsive Disorder (OCD) and the OCD Spectrum: A Systematic Review. Journal of Affective Disorders, 138(3), pp. 213-221. 

Lake J, Helgason C, Sarris J* (2011) Integrative Mental Health (IMH): Paradigm, Research, and Clinical Practice. Explore: The Journal of Science of and Healing 8(1), pp.50-57.

Pase M, Grima N, Sarris J* (2011) Do Long Chain Omega-3 Fatty Acids Reduce Arterial Stiffness? A Meta-Analysis of Randomized Controlled Trials. British Journal of Nutrition, 106(7), pp. 974-980.

Sarris J*, Panossian A, Schweitzer I, Stough C, Scholey A (2011) Herbal Medicine for the Treatment of Depression, Anxiety, and Insomnia: A Review of Psychopharmacology and Clinical Evidence. European Neuropsychopharmacology, 21(12), pp. 841-860.

Sarris J*, Ng C, Schweitzer I (2011) Use of "Omic" Technologies in Herbal Medicine in Psychiatry. Phytotherapy Research, 26(4), pp.522-527.

Manocha R, Black D, Sarris J, Stough C (2011) A Randomized, Controlled Trial of Meditation for Stress, Anxiety and Depressed Mood in Full-time Workers. Evidence-Based Complementary Medicine (ECam), 2011, pp. 960583. [Contributed to manuscript design, analysis of data and draft: 25%].

Pase M, Grima N, Sarris J* (2011) The effects of dietary and nutrient interventions on arterial stiffness: A systematic review. American Journal of Clinical Nutrition, 93(2), pp. 446-454.

Sarris J*, Hoenders R, Lake J (2011) Bipolar Disorder and Complementary Medicine: Current Evidence, Safety Issues, and Clinical Considerations. Journal of Alternative and Complementary Medicine, 17(10), pp. 881-890.

La Porte E, Sarris J*, Stough C, Scholey A (2011) Neurocognitive Effects of Kava (Piper methysticum): A Systematic Review. Human Psychopharmacology: Clinical and Experimental 26(2), pp. 102-111.

Camfield D, Sarris J*, Berk M (2011) Nutraceuticals in the Treatment of Obsessive Compulsive Disorder (OCD): A Review of Mechanistic and Clinical Evidence. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(4), pp.887-895.

Sarris J*, Byrne GJ (2011) Insomnia and Complementary Medicine. Sleep Medicine Reviews, 15(2), pp.99-106.

Sarris J*, Goncalves D, Robins-Wahlin, TB, Byrne GJ (2011) Complementary medicine use by middle-aged and older women: personality, mood and anxiety factors.  Journal of Health Psychology, 16(2), pp.314-321.

Sarris J*, (2011) Treatment of Clinical Depression: An Evidence-Based Integrative Complementary Medicine Model. Alter Ther Med, 17(4), pp.26-37.

Sarris J*, Teschke R, Stough C, Scholey A, Schweitzer (2011) Re-introduction of Kava (Piper methysticum) to the EU: Is there a Way Forward? Planta Med, 77(2), pp.107-110.

2010

Teschke R, Sarris J*, Glass X, Schultes J (2010) Kava Hepatoxicity: Solution Back to Basics? British Journal of Clinical Pharmacology, 71(3), pp.445-458.

Sarris J*, LaPorte E, Schweitzer I (2010) Kava (Piper methysticum): A Comprehensive Review of Efficacy, Safety, and Clinical Considerations. Aust NZ Journal of Psychiatry, 45(1), pp.27-35.

Teschke R, Sarris J*, Lebot V (2010) Kava Hepatotoxicity Solution: A Six-point Plan for New Standardization. Phytomedicine 18(2-3), pp.96-103. 

Sarris J*, Robins-Wahlin, T-B, Byrne GJ (2010) Comparative Use of Complementary Medicine, Allied Health and Manual Therapies By Middle-aged and Older Australian Women. Journal of Women and Aging (4):273-82. ERA A.

Sarris J*, Adams J, Kavanagh DJ (2010) An Explorative Qualitative Analysis of Participants' Experience of using Kava versus Placebo in an RCT. Aust J Med Herbalism, 22 (1), pp.12-16.

Panossian A, Wikman G, Sarris J* (2010) Rosenroot (Rhodiola rosea): Traditional Use, Chemical Composition, Pharmacology, and Clinical Efficacy, Phytomedicine, 17(7), pp. 481-493.

2009

Sarris J*, Schoendorfer N, Kavanagh DJ (2009) Major depressive disorder and nutritional medicine: A review of monotherapies and adjuvant treatments. Nutrition Reviews, 67(3), pp.125–131.

Sarris J*, Kavanagh DJ, Bone KM, Adams J, Byrne G, Deed G (2009) The Kava Anxiety Depression Spectrum Study (KADSS): A Randomized, Placebo-Controlled, Cross-over Trial using an Aqueous Extract of Piper methysticum. Psychopharmacology (Berlin), 205(3), pp. 399-407.

Sarris J*, Adams J, Wardle J (2009) Time for a re-assessment of Kava in the treatment of anxiety? Complementary Therapies in Medicine, 17(3), pp.121-122.

Sarris J*, Kavanagh DJ, Deed G, Bone KM (2009) St John's wort and Kava in the treatment of Major Depressive Disorder and comorbid anxiety: A randomised double-blind placebo controlled trial. Human Psychopharmacology: Clinical and Experimental, 24, pp.41-48.

Sarris J*, Kavanagh DJ (2009) Kava and St John's wort: Current Evidence for Use in Mood and Anxiety Disorders. Journal of Alternative and Complementary Medicine, 15(8), pp.827-836. 

Sarris J*, Kavanagh DJ, Adams J, Byrne G, Bone KM (2009) The Kava Anxiety Depression Spectrum Study (KADSS): A Mixed Methods Clinical Trial using an Aqueous Extract of Piper methysticum. Complementary Therapies in Medicine, 17(3), pp.176-178.

Sarris J*, Kavanagh DJ, Byrne GJ (2009) Adjuvant use of Nutritional and Herbal Medicines with Antidepressants, Mood stabilizers and Benzodiazepines. Journal of Psychiatric Research 44(1), pp.32-41.

2008

Kavanagh DJ, Sarris J* (2008) Conducting research in herbal and complementary medicine. Australian Journal of Medical Herbalism, 20(2).

Sarris J*, Kavanagh DJ, Newton R (2008) Depression and Exercise. Journal of Complementary Medicine, 7(3).

2007

Sarris J*, (2007) Herbal Medicine in the Treatment of Psychiatric Disorders: A systematic review. Phytotherapy Research, 21(8), pp.703-716

Conference Presentations

2016

ISAD and ISBD International Bipolar and Affective Disorders Conference; Amsterdam Holland.
Sarris J, Mischoulon, D, Murphy, H, Ng, C (2016). Adjunctive Nutraceuticals for the Treatment of Depression
(Accepted Oral Presentation)

Australian Naturopathic Summit; Gold Coast, Australia
(Invited Sponsored Plenary and Workshop)
Sarris J (2016). Blazing an Integrative Research Trail in the Medical Wilderness.

ARCVic OCD and Anxiety Seminar
(Invited Oral)
Sarris J (2016). Lifestyle Medicine for General Mental Health

Metagenics International Congress on Natural Medicine
(Invited Sponsored Keynote and Workshop)
Sarris J (2016). Natural Medicines for the Treatment of Psychiatric Disorders

Second Life Mental Health Conference
Virtual internet conference (Invited Keynote)
Sarris J (2016). Lifestyle Medicine and Supplementation for Mental Health and Psychiatric Disorders.

2015

Taiwan Mind-Body Medicine Conference; Taichung
(Invited Sponsored Symposium)
Sarris J (2015). Lifestyle Medicine for Enhancing Mental Health

Blackmores Institute Symposium; Melbourne
(Invited Sponsored Symposium)
Sarris J (2015). A Rapid-fire Update on Nutraceutical Research in Psychiatry

KavaCon- International Kava Conference. Chaminade University; Hawaii
(Invited Sponsored Plenary)
Sarris J (2015). Kava: The Pacific Anxiety-Reducing Medicine

Swinburne University of Technology CHumPsych Centre invited lecture; Melbourne
(Invited Oral)
Sarris J (2015). NAC in the Treatment of OCD

Nutrition in Medicine Conference; Melbourne
(Invited Oral)
Sarris J (2015). Advances in Nutraceutical Research for Psychiatric Disorders

NCNP Japan/UniMelb Collaborative Meeting; Tokyo
(Symposium Chair)
Sarris J et al (2015). Innovative Novel Pharmacotherapeutic Approaches to Treating Affective Disorders

International Anxiety Disorder Society Conference; Melbourne
(Invited Oral)
Kava and N-Acetyl Cysteine for the Treatment of Anxiety Disorders

Department of Psychiatry (UniMelb) 3rd Annual Symposium; Melbourne
(Invited Speaker)'
Sarris J (2015) Omega 3 in the Treatment of Mood Disorders

Taki Mai Kava Launch; Fiji
(Invited Keynote)
Sarris J (2015) Update on Kava Research

2014

ARCIM Inaugural Seminar (UTS), Sydney
(Invited  Keynote Speaker)
Sarris J (2014). Advances in the field of nutraceutical research in psychiatry

Biobalance conference, Gold Coast
(Invited Keynote Speaker)
Sarris J (2014). Nutrient supplementation in psychiatry

ISNPR Melbourne Conference
(Invited Keynote Speaker)
Sarris J (2014). Advances in nutraceutical use for mood and anxiety disorders

Austin Mental Health Grand Round
(Invited Speaker)
Sarris J (2014). Evidence-based Nutraceutical Prescription in Psychiatry

2013

ASPR Psychiatry Conference, Melbourne
(Invited Oral/Panellist)
Sarris et al. (2013) How to Undertake a Postdoc and Survive (Early Career Advice Workshop)

Department of Psychiatry Symposium Chair, Melbourne University
(Master of Ceremonies)
Sarris J et al. (2013)

ARCVic Anxiety and OCD Panel, Melbourne
(Invited Oral)
Sarris J (2013) Complementary Medicine and Lifestyle Approaches for Anxiety and OCD.

RANZCP Victorian Branch Psychiatry Conference
(Invited Plenary)
Sarris J (2013) Adjunctive Nutraceuticals with Psychotropic Medication

Monash University MPM/MPsych registrar teaching lecture
(Invited Oral Presentation)
Sarris J (2013). Complementary Medicines in Psychiatry.

University of Sydney, Mood disorders education and publication project
(Invited Paid Oral Webinar)
Sarris J (2013). Complementary Medicines for Mood Disorders

University of Melbourne MPM/MPsych registrar teaching lecture
(Invited Oral Presentation)
Sarris J (2013). Complementary Medicines in Psychiatry.

Integrative Medicine Education and Research Seminar, Melbourne, Australia
Invited Oral Presentation
Sarris J (2013) Nutrient-based Nutraceuticals for Mood Disorders

Alfred Health Nutrition Continuing Education Seminar, Melbourne
(Invited Oral Presentation)
Sarris J (2013). Advances in Nutraceutical Research in Psychiatry

Healthy Body Healthy Mind Presentation Series, Melbourne
(Invited Oral Presentation)
Sarris J (2013). Lifestyle and Complementary Medicine for Mental Health and Weight Management. The Melbourne Clinic.

American Psychiatric Association (APA) Conference, San Francisco, USA
(Invited Oral Presentation)
Sarris J, et al. (2013). Integrative Psychiatry Symposium

MediHerb Webinar (National Webcast)
(Invited Oral Paid Presentation)
Sarris J, et al. (2013). Herbal Anxiolytics for Treatment of Anxiety Disorders

The Melbourne Clinic Psychiatry Colloquium, Richmond, Melbourne
(Invited Oral Short Presentation) 
Sarris J (2013). N-Acetyl Cysteine in the Treatment of OCD

International Herbal Medicine Conference, Melbourne, Australia
(Invited Plenary)
Sarris J (2013). Herbal and Naturopathic Medicine for Anxiety Disorders

Bioceuticals Inaugural Research Symposium, Sydney, Australia
Invited Paid Oral Presentation
Sarris J (2013). Advances in Nutraceutical Research

Bioceuticals Inaugural Research Symposium, Sydney, Australia
Invited Paid Oral Workshop
Sarris J (2013). Advances in Nutraceutical Research

Bioceuticals Inaugural Research Symposium, Sydney, Australia
Invited Paid Panel
Sarris J (2013). Advances in Nutraceutical Research

Nutrition in Medicine International Conference, Sydney, Australia
Invited Oral Presentation
Sarris J (2013) Nutrient Supplements for Improving Mood

Melbourne University Honours "Translation in Science", Melbourne, Australia
Invited Oral Presentation
Sarris J (2013). Plant-Based Medicines for Treating Psychiatric Disorders

Biohorizons Conference (University of Qld), Brisbane, Australia
Invited Sponsored Plenary
Sarris J (2013). New Research Directions and Implications for Enhancing
Mental Health to Survive Uni 

Integrative Medicine Education and Research Seminar, Melbourne, Australia
Invited Oral Presentation
Sarris J (2013) Advances in Nutraceutical Research for Treatment of Mood and Anxiety Disorders

2012

University of the South Pacific, Suva, Fiji
(Invited Oral Presentation) 
Sarris J (2012). Efficacy and Safety of Kava (Piper methysticum)

Melbourne University Psychiatry Colloquium, Royal Melbourne Hospital
(Invited Oral Presentation) 
Sarris J (2012). Advances in Nutraceuticals for Mood and Anxiety Disorders

Complementary Healthcare Council (CHC) Conference, Sydney, Australia
Invited Presentation (travel grant)
Sarris J (2012). Utilising Nutraceutical Research to Benefit Consumers and Industry

University of Melbourne & Monash University MPM/MPsych registrar teaching lecture
(Invited Oral Presentation)
Sarris J (2011). Complementary Medicines in Psychiatry.

ARCVic Anxiety and OCD Week Seminar, Melbourne, Australia
Invited Presentation
Sarris J (2012). Lifestyle Modification and Complementary Medicine for OCD and General Anxiety

Centre for Human Psychopharmacology Research Meeting, Melbourne, Australia
Invited Presentation
Sarris J (2012). Advances in Natural Medicines, Nutraceuticals and Neurocognition.

University of Queensland MBBS [Nutritional Medicine Module], Qld, Australia
Invited Narrated Oral Web-presentation
Sarris J (2012). Nutritional Supplements for the Treatment of Mood Disorders

Travel Safe Seminar, Vision Australia, Melbourne, Australia
Invited Oral Presentation and Public Panel
Sarris J, Kiropoulos L (2012) Lifestyle Modifications and Psychology Techniques for Travel Anxiety in People with Vision Impairment

Sydney Integrative Mental Health Seminar, Australia
Invited Paid Oral Presentation
Sarris J (2012) St John's wort and Kava: Efficacy and Safety Data

Nutrition in Medicine International Conference, Melbourne, Australia
Invited Oral Presentation
Sarris J (2012) A Reason to be Happy: Current Evidence for SAMe and Omega 3 in the Treatment of Mood and Anxiety Disorders

Integrative Medicine Education and Research Seminar, Melbourne, Australia
Invited Oral Presentation
Sarris J (2012) Current Scientific Evidence for Nutraceuticals in Depression and Anxiety

International Society for Affective Disorders Congress, London, UK
(Invited Oral Symposium Presenter: Travel Award)
Sarris J (2012) Nutraceuticals for Mood and Anxiety Disorders

Melbourne University Academic Seminar Series
(Invited Oral Presentation) 
Sarris J (2012) Kava the Medicinal Plant: Recent Australian RCTs

Brain Health and Natural Medicine Conference, Melbourne, Australia
(Invited Panel Chair)
Sarris J, Amminger P, Jacka F, Braun L (2012) Translating Science into Better Mental Health

2011

University of Melbourne & Monash University MPM/MPsych registrar teaching lecture
(Invited Oral Presentation) Sarris J (2011).

Complementary Medicines in Psychiatry.University of Melbourne & Monash University MPM/MPsych registrar teaching lecture
(Invited Oral Presentation) Sarris J (2011). Complementary Therapies and Lifestyle Considerations in Psychiatry.

Depression Clinic & Research Program Colloquium, Harvard Medical School, Boston, USA
(Invited Oral Presentation).  Sarris J (2011). Kava in the Treatment of Anxiety and Depression: Clinical Evidence, Psychopharmacology, and Genetic Correlates

Bipolar Clinic & Research Program Colloquium, Harvard Medical School, Boston, USA
(Invited Oral Presentation).
Sarris J (2011). Adjunctive Use of Nutraceuticals in Bipolar Disorder.

Centre for Human Psychopharmacology Research Meeting, Melbourne
(Invited Presentation)
Sarris J (2011). Kava: Psychopharmacology, Clinical Evidence, Safety Issues, and Results from the Acute KALM Study.

ARCVic Anxiety and OCD Panel, Melbourne
(Invited Panel)
Sarris J et al. (2011) Complementary and Integrative Medicine Approaches for Anxiety and OCD.

Kava Conference, Australia National University (ANU), Canberra
(Invited Oral, travel paid)
Sarris, J (2011). Kava: Psychopharmacology, Clinical Evidence, Safety Issues, and its Global Re-institution.

3rd World Congress on Asian Psychiatry (WCAP), Melbourne
(Invited Symposium: Chair and Oral Presenter)
Sarris J (Chair), Jacka FN (Co-Chair), Singh N, Manocha R (2011)
Lifestyle Disorders for the Treatment of Mood Disorders: Back to Basics for Mental Health?

Clinical Controversies: Psychiatry Seminar, Sydney
(Invited Paid Oral Presentation)
Sarris J (2011). Complementary Medicines in Mood Disorders: Super Nova Treatments or a Black Hole for your Money?

Alfred/Monash University Integrative Medicine Education & Research Seminar: May
(Invited Oral Presentation) 
Sarris J (2011). Key Nutraceuticals in Psychiatry

National Herbalists Association of Australia National Seminar Series
(Invited Paid Oral Presentations in five states during 2011)
Sarris J (2011). Herbal Medicine in Psychiatry

Sierra Tuscon Integrative Mental Health Seminar, Arizona, USA
(Invited Oral Presentation, accommodation and flights (in part) paid for by organisers)
Dodds S, Sarris J, Herman P (2011). Research Priorities in Integrative Mental Health.

2010

Barwon Health Colloquium, Geelong (Invited Oral Presentation).
Sarris J (2011). Adjuvant use of nutraceuticals in Bipolar Disorder and Depression.

Woodford Festival Queensland (Invited Paid Oral Presentation)
Sarris J, Wardle J (2010)

The Low-Down on Clinical Naturopathy (public presentation)
Woodford Festival Queensland (Invited Paid Panel Presentation)
Sarris J et al. (2010)
Mind Games- Mental Health Panel (public presentation)

National Depression and Anxiety Conference, Melbourne Victoria. 2010.
Complementary Medicine in the Treatment of Depression: An Integrative Evidence-Based Clinical Model (Invited Oral Presentation)

International Herbal Medicine Conference: Coollangata, Gold Coast 2010
(Invited Oral Presentation)
Sarris J (2010). Insomnia and Complementary Medicine: Are You Asleep Yet? 

Generalised Anxiety Disorder (GAD) Seminar, Mental Health House, Melbourne, Victoria (Invited Oral Presentation)
Sarris J (2010) Complementary Medicine Treatments for GAD

The Melbourne Clinic Research Seminar: Richmond, Victoria 2010
Sarris J (2010) Kava and Anxiety (invited presentation)

The National Institute of Complementary Medicine Research Seminar, Hawthorn, Victoria 2010
Sarris J (2010) How to Conduct Systematic Reviews (invited presentation)

The Department of General Practice, The University of Melbourne, Melbourne, Victoria 2010
Sarris J, (2010) Herbal and Nutritional Medicine in Mood Disorders (invited presentation)

ASPR 2010 conference, Bondi Beach, Sydney, NSW.
Sarris J Schweitzer I, Kavanagh D, Byrne G (2010) Kava and Anxiety: an Australian RCT

Anxiety Recovery Centre Victoria (Invited Panel Oral Presentation)
Sarris J et al. (2010), OCD and Anxiety Panel
57th International Congress of Plant and Natural Product Research: Geneva Switzerland (Awarded an Oral Presentation Grant).

2009

Sarris et al. (2009) The Kava Anxiety Depression Spectrum Study (KADSS).

International Society for Affective Disorders (ISAD) conference: Brisbane Feb 2009
(Poster presentation)

Sarris J, Kavanagh DJ, Bone KM, Adams J, Byrne GJ, Deed G (2009). The Kava Anxiety Depression Spectrum Study (KADSS): A Randomized, Placebo-Controlled, Cross-over Trial using an Aqueous Extract of Piper methysticum

International Evidence-based Complementary Medicine Conference: University of New England, Armidale Mar 2009 (Oral Presentation)
Sarris J (2010) Complementary Medicine and Generalised Anxiety Disorder (Invited presentation)

2008

International Congress of Complementary Medicine Research: Sydney Mar 2008
(Poster Presentation)
Sarris J, Kavanagh DJ, Deed G, Bone KM (2008). St John's wort and Kava in the Treatment of Major Depressive Disorder and Comorbid Anxiety:

2007

World Psychiatric Congress Association: Melbourne Nov 2007
(Poster Presentation)
Sarris J, Kavanagh DJ, Deed G, Bone KM (2008). St John's wort and Kava in the Treatment of Major Depressive Disorder and Comorbid Anxiety